Behavior of regularity CD25+ CD4 T cells in vivo
体内规律性 CD25 CD4 T 细胞的行为
基本信息
- 批准号:7353359
- 负责人:
- 金额:$ 0.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-03-01 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:AccountingAllograftingAnimalsAntigen-Presenting CellsAntigensAutoimmune DiseasesAutoimmunityBehaviorCD4 Positive T LymphocytesCell ShapeCellsClinical ProtocolsConditionConsensusDendritic CellsDevelopmentDissectionExperimental ModelsFoundationsGoalsHumanIL2RA geneImmuneImmune ToleranceIn VitroKnowledgeLaboratoriesLeadLymphoid TissueLymphopeniaMeasuresMediatingMediator of activation proteinMusNumbersPeripheralPopulationProductionQualifyingRangeRegulationRoleSpecificitySuppressor-Effector T-LymphocytesSystemT-Cell DevelopmentT-LymphocyteT-Lymphocyte SubsetsTestingTrainingWorkbasecytokineimprovedin vivonovel strategiespreventreconstitutionresearch studyresponsesizetherapeutic targettumor
项目摘要
Regulatory CD25+CD4 T cells are important mediators of immunologic tolerance and are likely to
become a therapeutic target. However, their mechanisms in vivo remain largely unknown, and are
the main focus of this proposal. The summary of the preliminary work described here shows that 1)
we are able to purify in numbers sufficient for the proposed experiments antigen-specific
regulatory CD25+CD4 T_;_.!!._ from wild-type TCR Tg mice and antigen-specific regulatory CD25+CD4 T
cells expressing a single known TCR; 2) we have established two complementary in vivo systems to
measure suppressive effects of CD25+CD4 T cells on responder T cells in non-lymphopenic animals;
3) we are able to simultaneously visualize the behavior and cellular interactions of
antigen-specific CD25+CD4 T cells, antigen-specific responder T cells, and antigen-presenting
dendritic cells; 4) CD25+CD4 T cells reduce the size of the T cell population responding to
antigen and inhibit production of effector Thl and Th2 cytokines; and 5) CD25+CD4 T cells inhibit
homeostatic proliferation of naive T cells in lymphopenic mice. The laboratory is now
exceptionally poised to pursue the two specific aims in the proposal. In the first aim we will
define the cellular mechanisms of by which CD25+CD4 T cells inhibit the antigen-specific T cell
responses within the secondary lymphoid tissues. We will determine the fates of the dendritic
cells presenting the antigen as well the antigen-specific CD25+CD4 T cells and responder T cells.
In the second aim we will determine how CD25+CD4 T cells shape the development of the T cell
compartment during immune reconstitution by homeostatic proliferation. In particular, we will
test how CD25+CD4 T cells may regulate potentially auto-aggressive T cell clones under conditions
of lymphopenia. Although cellular mechanisms constitute the main focus of this proposal, the
experimental systems described are robust and are ideally suited for testing roles of specific
molecules in CD25+CD4 T cell-mediated immune regulation.
调节性CD25+CD4 T细胞是免疫耐受的重要介质,并且可能
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A causal link between lymphopenia and autoimmunity.
- DOI:10.1016/j.imlet.2004.10.022
- 发表时间:2005-04-15
- 期刊:
- 影响因子:4.4
- 作者:Khoruts A;Fraser JM
- 通讯作者:Fraser JM
A model of suppression of the antigen-specific CD4 T cell response by regulatory CD25+CD4 T cells in vivo.
体内调节性 CD25 CD4 T 细胞抑制抗原特异性 CD4 T 细胞反应的模型。
- DOI:10.1093/intimm/dxh213
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Thorstenson,KristenM;Herzovi,Laura;Khoruts,Alexander
- 通讯作者:Khoruts,Alexander
Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.
调节性 CD4 CD25 Foxp3 T 细胞选择性抑制淋巴细胞减少诱导的初始 T 细胞的自发增殖。
- DOI:10.4049/jimmunol.180.11.7305
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Winstead,ColleenJ;Fraser,JoanneM;Khoruts,Alexander
- 通讯作者:Khoruts,Alexander
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER KHORUTS其他文献
ALEXANDER KHORUTS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER KHORUTS', 18)}}的其他基金
Identification of Intestinal Bacteria Protective against C. Difficile Colitis
鉴定可预防艰难梭菌结肠炎的肠道细菌
- 批准号:
8206591 - 财政年份:2011
- 资助金额:
$ 0.83万 - 项目类别:
Identification of Intestinal Bacteria Protective against C. Difficile Colitis
鉴定可预防艰难梭菌结肠炎的肠道细菌
- 批准号:
8023787 - 财政年份:2011
- 资助金额:
$ 0.83万 - 项目类别:
Translational control of regulatory T cell induction
调节性 T 细胞诱导的翻译控制
- 批准号:
7914404 - 财政年份:2009
- 资助金额:
$ 0.83万 - 项目类别:
Translational control of regulatory T cell induction
调节性 T 细胞诱导的翻译控制
- 批准号:
7701395 - 财政年份:2009
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regularity CD25+ CD4 T cells in vivo
体内规律性 CD25 CD4 T 细胞的行为
- 批准号:
6850666 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regulatory CD25+ CD4 T cells in vivo
体内调节性 CD25 CD4 T 细胞的行为
- 批准号:
7188672 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regulatory CD25+ CD4 T cells in vivo
体内调节性 CD25 CD4 T 细胞的行为
- 批准号:
6609957 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regularity CD25+ CD4 T cells in vivo
体内规律性 CD25 CD4 T 细胞的行为
- 批准号:
7060654 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regularity CD25+ CD4 T cells in vivo
体内规律性 CD25 CD4 T 细胞的行为
- 批准号:
6702593 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
Behavior of regularity CD25+ CD4 T cells in vivo
体内规律性 CD25 CD4 T 细胞的行为
- 批准号:
7026397 - 财政年份:2003
- 资助金额:
$ 0.83万 - 项目类别:
相似海外基金
Establishment of novel osteochondral allografting combined with growth factor- collagen-binding domain fusion technology
新型同种异体骨软骨移植联合生长因子-胶原蛋白结合域融合技术的建立
- 批准号:
26462277 - 财政年份:2014
- 资助金额:
$ 0.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Translating PTH Therapy as an Adjuvant for Structural Allografting
将 PTH 疗法转化为结构性同种异体移植的佐剂
- 批准号:
8344380 - 财政年份:2012
- 资助金额:
$ 0.83万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7878675 - 财政年份:2009
- 资助金额:
$ 0.83万 - 项目类别:
Composite Allografting for Promoting Survival of Corneal Transplants
复合同种异体移植促进角膜移植的存活
- 批准号:
7677758 - 财政年份:2009
- 资助金额:
$ 0.83万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7466112 - 财政年份:2008
- 资助金额:
$ 0.83万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8010394 - 财政年份:2008
- 资助金额:
$ 0.83万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
8208131 - 财政年份:2008
- 资助金额:
$ 0.83万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7575273 - 财政年份:2008
- 资助金额:
$ 0.83万 - 项目类别:
Augmenting Antitumor Immunity after Allografting
增强同种异体移植后的抗肿瘤免疫力
- 批准号:
7765518 - 财政年份:2008
- 资助金额:
$ 0.83万 - 项目类别: